What is it about?

Sphingosine kinase 1-interacting protein has been reported as a regulator of insulin secretion. It might be a new target for treating diabetes. So it is important for us to understand the mechanism and other metabolic changes in SKIP deficient mice to develop novel drugs for treating these diseases.

Featured Image

Read the Original

This page is a summary of: Sphingosine kinase 1–interacting protein is a dual regulator of insulin and incretin secretion, The FASEB Journal, February 2019, Wiley,
DOI: 10.1096/fj.201801783rr.
You can read the full text:

Read

Contributors

The following have contributed to this page